Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected with hidradenitis suppurativa (HS), discusses current knowledge on the impact of diet and other holistic care strategies in the management of HS.
Some people with hidradenitis suppurativa (HS) have shown benefit with dietary strategies, but there remain gaps in clinical knowledge regarding the holistic management of the overall patient population, said Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected with hidradenitis suppurativa (HS),
Transcript
Can you discuss holistic considerations for the management of HS and any gaps in knowledge here?
So, one of the pressing needs or one of the pressing topics with patients, and one of the things I forgot to mention in my road to treatment, diet is a huge, huge topic amongst the HS patient community. So, at one point, when I had to leave the Humira [adalimumab] study and I was going to look at more holistic ways of treating this because I thought that was probably better to do with pregnancy, I had gone to a holistic doctor—a functional/integrative medicine doctor or something like that—and he sent me home with like $400 worth of medical supplements.
Paste for your GI [gastrointestinal] tract, it was an orange salve, pills, it all smelled horrible. He gave me this presentation with all of these little circles on what he thought was affecting the immune system and how this was to play. And I gave it an honest-to-god shot, but it just didn't work for me.
Patients with HS are very curious about diet. We get asked that a lot and a lot of doctors get asked a lot about that, and there's all kinds of thoughts and theories. As general advice, we always say just try a basic elimination diet. Like if you think it's potatoes, just eliminate them first, but don't go full autoimmune paleo. I don't know if you ever heard of that. You can't drink coffee on it, and it's extremely restrictive. They talk about nightshade vegetables and stuff like that.
Some patients have had success with dairy and removing dairy out of their diet—I know that that's the case for acne as well. But it's all very individualized, and right now there's not one conclusive thing that kind of works on everybody. Like Humira has great success, but it doesn't work on everybody. And so that kind of tells me that the nail hasn't quite been hit on the head. But diet is something that patients with HS always seem to want to talk about.
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Patients With Advanced, Recurrent Melanoma May Experience Lasting AEs From ICM Therapy
May 9th 2024A cross-sectional, mixed-methods study found that adverse effects (AEs) can occur even after 1 year of treatment with immune checkpoint modulator (ICM) therapy in patients with melanoma.
Read More